CC
RVMD icon

Checkpoint Capital’s Revolution Medicines RVMD Stock Holding History

Checkpoint Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.9M Buy
410,353
+147,814
+56% +$21.6M 19.72% 3
2026
Q1 		$25.5M Sell
262,539
-107,461
-29% -$10.9M 9.16% 3
2025
Q4 		$29.5M Sell
370,000
-122,300
-25% -$8.02M 9.21% 4
2025
Q3 		$23M Buy
492,300
+212,300
+76% +$8.31M 7.7% 5
2025
Q2 		$10.3M Sell
280,000
-112,011
-29% -$4.3M 4.8% 5
2025
Q1 		$13.9M Buy
392,011
+182,011
+87% +$7.39M 7.61% 3
2024
Q4 		$9.19M Buy
+210,000
New +$10.6M 4.68% 7

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Checkpoint Capital's RVMD Position: Q2 2026 in Review

Checkpoint Capital increased its Revolution Medicines (RVMD) stake by 56% in Q2 2026, buying an estimated $21.6M and bringing the position to 410,353 shares worth $76.9M. The position accounts for 19.72% of the portfolio, ranked #3.

Checkpoint Capital first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Checkpoint Capital held 410,353 shares of Revolution Medicines worth $76.9M as of Q2 2026.
  • Checkpoint Capital bought 147,814 Revolution Medicines shares in Q2 2026, an estimated $21.6M.
  • Revolution Medicines made up 19.72% of Checkpoint Capital's portfolio in Q2 2026, its #3 holding.
  • Checkpoint Capital first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Checkpoint Capital's 13F filing for Q2 2026, filed 14 Aug 2026.